This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Japan Tobacco Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Junichiro Tsuruha: Innovator in Hepatitis C Treatment
Introduction
Junichiro Tsuruha is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target hepatitis C. His work has the potential to impact the treatment and management of this viral infection.
Latest Patents
Tsuruha holds a patent for a piperazine compound that serves as an HCV polymerase inhibitor. The patent describes a compound represented by a specific formula, which is effective in showing anti-HCV activity. This compound is useful as an agent for the prophylaxis or treatment of hepatitis C, highlighting its importance in the pharmaceutical industry.
Career Highlights
Throughout his career, Junichiro Tsuruha has been associated with Japan Tobacco Inc., where he has focused on research and development in the field of antiviral agents. His innovative approach has led to advancements in the treatment of hepatitis C, showcasing his dedication to improving public health.
Collaborations
Tsuruha has worked alongside notable colleagues such as Hiroyuki Abe and Masahiro Tanaka. Their collaborative efforts have contributed to the success of various projects within the company, further enhancing the impact of their research.
Conclusion
Junichiro Tsuruha's contributions to the field of hepatitis C treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in antiviral therapies.